BlinkLab Limited
1 day chart
Get A$10 trading credit to start you off
Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.
Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.
T&Cs apply
About BB1
BlinkLab Limited (BB1) is an innovative digital healthcare company leveraging smartphones, computer vision, AI and machine learning to diagnose neurodevelopmental conditions. Has fully developed a smartphone based diagnostic platform for autism, ADHD, schizophrenia, and other neurodevelopmental conditions. The tests include, but are not limited to, eyeblink conditioning (EBC), prepulse inhibition of acoustic startle (PPI) and habituation of eye blink response which serve as biomarkers for neurological and psychiatric disorders (BlinkLab Tests).
Find out what a historical investment in BlinkLab Limited would be worth today using our BB1 stock calculator.
Sector
Health Care
CEO
Dr Hendrikus Johannes Boele
Industry
Health Care Technology
Website
blinklab.org
$30M
-13.22
-
$0.36
$0.34
$0.35
$0.48
$0.21
Ready to start your investing journey with Stake?
Open an accountAnnouncements
Section 708A Notice
Thu, May 8, 2025
Application for quotation of securities - BB1
Wed, May 7, 2025
Successful Placement of A$7.66M to Underpin Growth Strategy
Wed, Apr 30, 2025
BB1 FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in BB1
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BB1
on Stake
Buy BB1 from A$3 brokerage
Invest in 2,500+ Aussie stocks and ETFs
CHESS-sponsored ASX trades
